ArticleJournal of ovarian research2013

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR).

Sabine Heublein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.